1. Home
  2. RBC vs ASND Comparison

RBC vs ASND Comparison

Compare RBC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBC
  • ASND
  • Stock Information
  • Founded
  • RBC 1919
  • ASND 2006
  • Country
  • RBC United States
  • ASND Denmark
  • Employees
  • RBC N/A
  • ASND N/A
  • Industry
  • RBC Metal Fabrications
  • ASND Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBC Industrials
  • ASND Health Care
  • Exchange
  • RBC Nasdaq
  • ASND Nasdaq
  • Market Cap
  • RBC 9.7B
  • ASND 9.1B
  • IPO Year
  • RBC 2005
  • ASND 2015
  • Fundamental
  • Price
  • RBC $347.18
  • ASND $156.97
  • Analyst Decision
  • RBC Buy
  • ASND Strong Buy
  • Analyst Count
  • RBC 8
  • ASND 16
  • Target Price
  • RBC $357.67
  • ASND $213.88
  • AVG Volume (30 Days)
  • RBC 145.3K
  • ASND 587.4K
  • Earning Date
  • RBC 05-16-2025
  • ASND 05-01-2025
  • Dividend Yield
  • RBC N/A
  • ASND N/A
  • EPS Growth
  • RBC 22.03
  • ASND N/A
  • EPS
  • RBC 7.30
  • ASND N/A
  • Revenue
  • RBC $1,612,300,000.00
  • ASND $398,509,511.00
  • Revenue This Year
  • RBC $6.13
  • ASND $62.61
  • Revenue Next Year
  • RBC $8.03
  • ASND $72.16
  • P/E Ratio
  • RBC $48.19
  • ASND N/A
  • Revenue Growth
  • RBC 4.63
  • ASND 12.06
  • 52 Week Low
  • RBC $260.53
  • ASND $111.09
  • 52 Week High
  • RBC $372.83
  • ASND $183.00
  • Technical
  • Relative Strength Index (RSI)
  • RBC 63.09
  • ASND 49.35
  • Support Level
  • RBC $337.43
  • ASND $156.02
  • Resistance Level
  • RBC $346.02
  • ASND $183.00
  • Average True Range (ATR)
  • RBC 7.40
  • ASND 7.31
  • MACD
  • RBC 2.98
  • ASND -0.83
  • Stochastic Oscillator
  • RBC 92.00
  • ASND 21.10

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of highly engineered precision bearings, components and essential systems for the industrial, defense and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The end market is the United States of America. The company has two reportable segments: Aerospace Defense segment represents the end markets for the company's highly engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and Industrial segment represents the end markets for the company's engineered bearings and precision components used in various industrial applications. It derives maximum revenue from Industrial Segment.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Share on Social Networks: